This is an external link. Click “OK” to continue.
Antibe hosted a conference call to discuss the recent positive results of the Phase IIB dose-ranging, efficacy study for otenaproxesul (ATB-346). Management provided a brief summary of the results which was followed by a Q&A session for analysts. Please click on the “Read” link below to listen to an audio replay of the call.
LD Micro is an independent resource for investors in the microcap space, offering several influential events annually (Invitational, Summit, and Main Event). The LD500 is designed to introduce investors to select companies in a virtual event.
The TSX Venture 50™ Capital Conference introduces the Venture Top 50 companies to active top-level capital finance individuals through a day of scheduled one-on-one meetings. Antibe has also been invited to participate in the conference for the second year in a row. Winners were selected based on market capitalization growth, share price appreciation and trading … Continued
The PAINWeek Live Virtual Conference will provide an expansive, multidisciplinary curriculum presented by current and emerging thought leaders. PAINWeek is a major resource for frontline practitioners treating acute and chronic pain. For more than a decade, they have presented over 12,000 hours of content across national and regional conferences, conducting hundreds of expert opinion interviews, … Continued
Please join Dan Legault, our CEO, in his live presentation at the Oppenheimer Fall Healthcare Life Sciences & MedTech Summit on Tuesday, September 22, 2020 at 9:10am (Eastern Time). The summit is a major annual event for the life sciences industry, featuring company presentations, fireside chats, and 1-on-1 meetings with companies along with several keynote … Continued
As Europe’s largest life science partnering conference, BIO-Europe offers many opportunities to engage with global life science partners. Key biotech and pharma leaders who will discuss the latest industry trends in workshops and panels.
Summit will be chaired by Dr. Joseph Stauffer, Antibe’s Chief Medical Officer. Topics will include: Getting Back on Track: Moving past COVID-19 to regain successful trial operations and combat this new era of challenges A Thrust into the Virtual World: Unlocking the full potential of siteless clinical trials, evaluating the opportunities and analyzing best practices … Continued
Please sign up to our mailing list to receive regular news updates via e-mail.